PulseAugur
EN
LIVE 11:29:40
中文(ZH) 药明康德:全面上调2026年业绩指引,预计整体收入由513-530亿元上调至585-605亿元

WuXi AppTec raises 2026 revenue forecast on strong client product success

WuXi AppTec has significantly raised its 2026 revenue forecast, projecting an increase from RMB 51.3-53 billion to RMB 58.5-60.5 billion. This upward revision is attributed to the success of multiple client products and the company's CRDMO model. The projected year-over-year growth rate for continuing operations has also been increased from 18%-22% to 35%-39%. AI

IMPACT This revenue forecast increase for WuXi AppTec suggests strong growth in the AI/ML development and manufacturing sector, indicating increased demand for their CRDMO services.

RANK_REASON Company financial guidance update with significant revenue and growth rate increases. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

WuXi AppTec raises 2026 revenue forecast on strong client product success

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    WuXi AppTec: Fully Raises 2026 Performance Guidance, Expects Overall Revenue to Increase from 51.3-53.0 Billion Yuan to 58.5-60.5 Billion Yuan

    36氪获悉,药明康德公告,得益于多个客户产品的更大成功,以及公司独特的CRDMO模式和卓越的管理与执行,公司全面上调2026年全年业绩指引。预计2026年公司整体收入由人民币513-530亿元上调至人民币585-605亿元,持续经营业务收入同比增速由18%-22%上调至35%-39%。